91
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD

, , , , , , , , , , & show all
Pages 1163-1186 | Published online: 17 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Alfredo Chetta, Nicola Facciolongo, Cosimo Franco, Laura Franzini, Alessio Piraino & Carmelina Rossi. (2022) Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New Opportunities. Therapeutics and Clinical Risk Management 18, pages 965-979.
Read now
David B Price, William Henley, José Eduardo Delfini Cançado, Leonardo M Fabbri, Huib A M Kerstjens, Alberto Papi, Nicolas Roche, Elif Şen, Dave Singh, Claus F Vogelmeier, Sara Barille, Elena Nudo, Victoria Carter, Derek Skinner, Rebecca Vella & George Georges. (2022) Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 355-370.
Read now
Jose Luis López-Campos, Laura Carrasco Hernández, Borja Ruiz-Duque, Rocio Reinoso-Arija & Candelaria Caballero-Eraso. (2021) Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2065-2076.
Read now
Jaco Voorham, Simonetta Baldi, Luigi Santoro, Marjan Kerkhof, Marco Contoli, Leonardo M Fabbri, Huib A M Kerstjens, Jose Luis López-Campos, Nicolas Roche, Dave Singh, Claus F Vogelmeier & David B Price. (2020) Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2739-2750.
Read now
Rupert Jones, Jessica Martin, Vicky Thomas, Derek Skinner, Jonathan Marshall, Martina Stagno d’Alcontres & David Price. (2017) The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2445-2454.
Read now
Kieran J Rothnie, Hana Müllerová, Sara L Thomas, Joht S Chandan, Liam Smeeth, John R Hurst, Kourtney Davis & Jennifer K Quint. (2016) Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records. Clinical Epidemiology 8, pages 771-782.
Read now
Anthony D’Urzo, James F Donohue, Peter Kardos, Marc Miravitlles & David Price. (2015) A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 16:12, pages 1845-1860.
Read now

Articles from other publishers (2)

I. V. Demko, L. M. Kudelya, E. A. Sobko, I. A. Solov'eva, I. N. Trofimenko, A. V. Tetenevа, A. A. Grebenyuk, N. G. Ganyukova, N. S. Gyrgeshkinova, S. A. Luk'yanov, Ch. Ch. Mandarzhap & O. A. Meshcheryakova. (2020) Diagnostic and treatment options for patients with COPD as part of real clinical practice. Approaches to the treatment of patients with various phenotypes according to GOLD (2019): materials of the Council of Experts of the Siberian Federal District, Chita and Buryatia, dated 03.15.19. Russian Pulmonology 30:2, pages 245-251.
Crossref
O. N. Titova, N. A. Kuzubova & E. S. Lebedeva. (2020) The protective effect of beclomethasone dipropionate in the modeling of chronic obstructive pulmonary disease. Russian Pulmonology 30:1, pages 61-68.
Crossref